NO20076391L - Compositions and methods for treating states related to efrine signals with cupredoxin - Google Patents

Compositions and methods for treating states related to efrine signals with cupredoxin

Info

Publication number
NO20076391L
NO20076391L NO20076391A NO20076391A NO20076391L NO 20076391 L NO20076391 L NO 20076391L NO 20076391 A NO20076391 A NO 20076391A NO 20076391 A NO20076391 A NO 20076391A NO 20076391 L NO20076391 L NO 20076391L
Authority
NO
Norway
Prior art keywords
compositions
methods
efrine
cupredoxin
signals
Prior art date
Application number
NO20076391A
Other languages
Norwegian (no)
Inventor
Ananda Chakrabarty
Tapas Das Gupta
Tohru Yamada
Arsenio Fialho
Anita Chaudhari
Yonghua Zhu
Original Assignee
Univ Illinois
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US11/244,105 external-priority patent/US7691383B2/en
Application filed by Univ Illinois filed Critical Univ Illinois
Publication of NO20076391L publication Critical patent/NO20076391L/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/21—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pseudomonadaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Abstract

Den foreliggende oppfinnelsen er relatert til sammensetninger og fremgangsmåter for anvendelse av kupredoksiner og varianter, derivater og strukturelle ekvivalenter av kupredoksiner som interfererer med efrinsignalsystemet i mammalske celler. Spesifikt er oppfinnelsen relatert til sammensetninger og fremgangsmåter som anvender kupredoksiner slik som azurin, rusticyanin og plastocyanin og varianter, derivater og strukturelle ekvivalenter derav, for å behandle cancer i pattedyr.The present invention relates to compositions and methods for the use of cupredoxins and variants, derivatives and structural equivalents of cupredoxins that interfere with the ephrin signaling system in mammalian cells. Specifically, the invention relates to compositions and methods using cupredoxins such as azurine, rusticyanin and plastocyanin and variants, derivatives and structural equivalents thereof, for the treatment of mammalian cancer.

NO20076391A 2005-05-20 2007-12-11 Compositions and methods for treating states related to efrine signals with cupredoxin NO20076391L (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US68281205P 2005-05-20 2005-05-20
US11/244,105 US7691383B2 (en) 2004-10-07 2005-10-06 Cupredoxin derived transport agents and methods of use thereof
US76474906P 2006-02-03 2006-02-03
PCT/US2006/019684 WO2007018671A2 (en) 2005-05-20 2006-05-19 Compositions and methods for treating conditions related to ephrin signaling with cupredoxins

Publications (1)

Publication Number Publication Date
NO20076391L true NO20076391L (en) 2008-02-15

Family

ID=37727776

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20076391A NO20076391L (en) 2005-05-20 2007-12-11 Compositions and methods for treating states related to efrine signals with cupredoxin

Country Status (10)

Country Link
EP (1) EP1888106A4 (en)
JP (1) JP2008539795A (en)
KR (1) KR20080040631A (en)
AU (1) AU2006277009A1 (en)
BR (1) BRPI0612424A2 (en)
CA (1) CA2608512A1 (en)
IL (1) IL187138A0 (en)
MX (1) MX2007014598A (en)
NO (1) NO20076391L (en)
WO (1) WO2007018671A2 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7381701B2 (en) 2001-02-15 2008-06-03 The Borad Of Trustees Of The University Of Illinois Compositions and methods for treating conditions related to ephrin signaling with cupredoxins
US7556810B2 (en) 2005-07-19 2009-07-07 The Board Of Trustees Of The University Of Ilinois Compositions and methods to control angiogenesis with cupredoxins
US9096663B2 (en) 2001-02-15 2015-08-04 The Board Of Trustees Of The University Of Illinois Compositions and methods for treating conditions related to ephrin signaling with cupredoxins and mutants thereof
AU2005327535A1 (en) 2004-10-07 2006-08-24 Ananda Chakrabarty Cupredoxin derived transport agents and methods of use thereof
JP2009502797A (en) * 2005-07-19 2009-01-29 ザ・ボード・オブ・トラスティーズ・オブ・ザ・ユニバーシティ・オブ・イリノイ Compositions and methods for controlling angiogenesis with cupredoxins
EP1904642A4 (en) 2005-07-19 2008-11-26 Univ Illinois Transport agents for crossing the blood-brain barrier and into brain cancer cells, and methods of use thereof
BRPI0714987A2 (en) * 2006-09-14 2013-07-30 Trutees Of The University Of Illinoi Board Of cupredoxin cancer prevention compositions and methods
EP2117573A4 (en) * 2007-01-11 2011-02-16 Univ Illinois Compositions and methods for treating conditions related to ephrin signaling with cupredoxins and mutants thereof
PL2199390T3 (en) 2007-08-30 2017-06-30 Daiichi Sankyo Company, Limited Anti-epha2 antibody
KR101102829B1 (en) * 2008-09-12 2012-01-05 재단법인 제주테크노파크 Extract of Ulva pertusa and Its Use as Anti-inflammatory Medicine
CN110090295B (en) * 2018-01-29 2022-12-23 武汉康理通科技有限公司 Application of Ephrin-B1 in preparation of medicine for treating inflammatory bowel disease

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1411963A4 (en) * 2001-02-15 2005-01-19 Univ Illinois Cytotoxic factors for modulating cell death
US7491394B2 (en) * 2001-02-15 2009-02-17 The Board Of Trustees Of The University Of Illinois Cytotoxic factors for modulating cell death

Also Published As

Publication number Publication date
BRPI0612424A2 (en) 2009-01-27
AU2006277009A1 (en) 2007-02-15
KR20080040631A (en) 2008-05-08
EP1888106A2 (en) 2008-02-20
WO2007018671A2 (en) 2007-02-15
MX2007014598A (en) 2008-02-07
IL187138A0 (en) 2008-02-09
WO2007018671A3 (en) 2007-11-22
EP1888106A4 (en) 2009-01-14
JP2008539795A (en) 2008-11-20
CA2608512A1 (en) 2007-02-15

Similar Documents

Publication Publication Date Title
NO20076391L (en) Compositions and methods for treating states related to efrine signals with cupredoxin
NO20091326L (en) Indazole derivatives as modulators of interleukin-1 receptor-associated kinase
NO20170633A1 (en) Compounds of indolamine-2,3-dioxygenase for use in the treatment of cancer in combination with an anti-PD-1 antibody.
NO20064976L (en) Azanidols useful as inhibitors of rock and other protein kinases
MX2009004986A (en) Methods of treating hemolytic anemia.
DE602004006433D1 (en) PYRROL SUBSTITUTED INDOLE AS INHIBITORS OF PAI-1
NO20083153L (en) Chemical connections
NO20070487L (en) 3-aminocyclopentanecarboxamides as modulators of chemokine receptors.
EA201000094A1 (en) Derivatives of pyrimidinyl-pyridazinone
NO20081354L (en) Double variable domain immunoglobin and methods thereof
NO20083501L (en) Azaindoles useful as inhibitors of Janus kinases
EA200601766A1 (en) Imidazole Derivatives
NO20073628L (en) Pyridones useful as inhibitors of kinases
MY155418A (en) Dioxa-bicyclo[3.2.1]octane-2,3,4-triol derivatives
NO20061194L (en) Mitotic kinesin inhibitors
NO20071619L (en) Process for the preparation of indazole compound
EA201171174A1 (en) HEPATITIS C VIRUS REPLICATION INHIBITORS
EA200602062A1 (en) AMIDOCONOMINATION AND THEIR APPLICATION AS PHARMACEUTICAL FACILITIES
NO20082509L (en) Pyridopyrazine derivatives and their use
MX354402B (en) Small molecule inhibitors of the pleckstrin homology domain and methods for using same.
UA83311C2 (en) 3-aminocyclopentanecarboxamides as modulators of chemokine receptors
EA200601894A1 (en) DERIVATIVES OF PIPERASINILIPIPERIDINE AS ANTAGONISTS OF CHEMOKINE RECEPTOR
WO2010031056A3 (en) Methods and compositions for modulating ire1, src, and abl activity
NO20074943L (en) Roflumilast for the treatment of diabetes mellitus
WO2007111948A3 (en) Inhibitors of protein prenyltransferases

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application